Table 2

Efficacy of treatment

Effectiveness on the basis of increase of dosage

Relapse on the basis of decrease of dosage

Improvement of symptoms

Fever

Rigor

Both

Not mentioned

Dantrolene monotherapy

2/37 (5.4%)

3/37 (8.1%)

9 (24.3%)

4 (10.8%)

9 (24.3%)

15 (40.5%)

Dantrolene with additive medication

5/82 (6.1%)

7/82 (8.5%)

10 (12.2%)

3 (3.7%)

12 (14.6%)

57 (69.5%)

Other medication

4/101 (4.0%)

17/101 (16.8%)

12 (11.9%)

2 (2.0%)

14 (13.9%)

73 (72.3%)

Only supportive therapy

Not applicable

Not applicable

1 (2.0%)

-

1 (2.0%)

49 (96.1%)

Reulbach et al. Critical Care 2007 11:R4   doi:10.1186/cc5148